18 February 2020 – HA Enhanced Laboratory Surveillance Programme extends to outpatients with mild symptoms

Type of Intervention: Specific Action
Sectors Involved: Health
Level of Jurisdiction: Special Administrative Region
Lead People/Agency: Hospital Authority Chief Manager (Quality & Standards) Dr Lau Ka-hin

Overview: HA Enhanced Laboratory Surveillance Programme extends to outpatients with mild symptoms
Full details here: https://www.ha.org.hk/haho/ho/pad/200218EENG.pdf

Other links: 1
Type of Justification: Advice of INTERNAL government advisory committee or group
Source of Evidence or Justification: Scientific Committee of the Centre for Health Protection (CHP)
Evidence/Justification: “To help detect mild cases in the community
and to have a better understanding of the epidemiological situation”